Catalent Inc (NYSE:CTLT)
| 115.34 BATS BZX Real-Time Price As of 11:09am ET |  +1.63 / +1.43%Today’s Change | 31.04 Today|||52-Week Range 127.68 | +10.83% Year-to-Date |
Latest CTLT News | Press Releases
| Should Investors Worry About Moderna's Vaccine Delays? Feb 23 / MotleyFool.com - Paid Partner Content | Moderna Hits a Short-Term Vaccine Manufacturing Delay, Still on Track for First 100 Million Doses by End of March Feb 16 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 113.71 |
| Today’s open | 114.78 |
| Day’s range | 114.15 - 116.07 |
| Volume | 218,267 |
| Average volume (3 months) | 1,126,523 |
| Market cap | $19.4B |
Data as of 11:09am ET, 03/01/2021
Growth & Valuation
| Earnings growth (last year) | +26.20% |
| Earnings growth (this year) | +33.90% |
| Earnings growth (next 5 years) | +19.64% |
| Revenue growth (last year) | +22.89% |
| P/E ratio | 63.3 |
| Price/Sales | 3.61 |
| Price/Book | 6.39 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HZNPHorizon Therapeutics... | +0.28 | +0.31% |
| VTRSViatris Inc | +0.18 | +1.21% |
| ALNYAlnylam Pharmaceutic... | +1.13 | +0.76% |
| INCYIncyte Corp | +1.54 | +1.96% |
Data as of 11:09am ET, 03/01/2021
Financials
| Next reporting date | May 11, 2021 |
| EPS forecast (this quarter) | $0.74 |
| Annual revenue (last year) | $3.1B |
| Annual profit (last year) | $173.0M |
| Net profit margin | 5.59% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Somerset, New Jersey |
Forecasts
